Showing papers in "Journal of Cardiac Failure in 2013"
TL;DR: In patients with decompensated heart failure and hyponatremia, standard therapy is associated with less weight loss and dyspnea relief, and unfavorable longer-term outcomes compared to those with normonat Remia.
137 citations
TL;DR: Preoperative RV FAC, estimated RAP, and LAV index predict postoperative RVF in patients undergoing LVAD implantation and may be combined into a simple echocardiographic scoring system to provide an additional tool to risk-stratify patients being evaluated for LVad implantation.
117 citations
TL;DR: Despite recommendations, PCCs are not being initiated until the last month of life, and earlier referral for PCC may allow for integration of a broader array of palliative care services.
106 citations
TL;DR: The prognostic value of sST2 was not influenced by renal function, and on top of other biomarkers, s ST2 improved long-term prediction in patients with renal insufficiency even more than in the total cohort.
86 citations
TL;DR: Dietary Na intake, but not MA, was improved by PFE and FPI compared with UC, and both groups increased HF knowledge immediately after intervention.
84 citations
TL;DR: Medication nonadherence and depressive symptoms had a negative synergistic effect on cardiac event-free survival in patients with HF.
76 citations
Veterans Health Administration1, Western University of Health Sciences2, University of Illinois at Chicago3, University of California, San Francisco4, University of Pittsburgh5, Campbell University6, Scripps Health7, University of Colorado Denver8, University of North Carolina at Chapel Hill9, University of Wisconsin-Madison10
TL;DR: Positive outcomes associated with clinical pharmacist activities support the value of making this resource available to HF teams.
74 citations
TL;DR: AA patients with PPCM in the USA have a different clinical profile and worse prognosis compared with white patients and further research to evaluate potentially correctable causes for these differences is warranted.
73 citations
TL;DR: Urinary NGAL, KIM-1 and IL-18 are relatively modest predictors of AKI in ADHF, and among these novel renal biomarkers examined, further investigations regarding the prognostic value of urinary IL- 18 are warranted.
73 citations
TL;DR: ED and serial ST2 measurements are independent predictors of 1-year mortality in AHF and the interaction between ST2 levels, treatment at discharge, and 1- year mortality is assessed.
72 citations
TL;DR: PH and RV function provide incremental prognostic information in ADHF and the estimation of PASP may be warranted in the standard assessment of ADHF.
TL;DR: In this article, the authors investigated the measurement of soluble ST2 (sST2) in stable heart failure with a normal ejection fraction (HFNEF) in hypertensive patients using Echocardiography and serum N-terminal pro-B-type natriuretic peptide (NT-proBNP) and sST2 concentrations.
TL;DR: The ANTHEM-HF study has been designed to address several key clinical questions about the role of autonomic regulation therapy (ART) in patients with LV dysfunction and chronic symptomatic heart failure and should provide additional and valuable information regarding the safety and the relationship between the site and intensity of ART.
TL;DR: Perceived emotional/informational support is associated with betterSelf-care maintenance and possibly better self-care management and greater self-Care confidence is one mediating mechanism.
TL;DR: HF patients' comprehension of discharge instructions is inadequate, and patients with limited education and those that do not speak English as a primary language are more likely to have poorer discharge understanding and higher rates of 30-day readmissions.
TL;DR: A significant overall QoL improvement emerged after conducting psychosocial interventions with CHF patients and no significant advantage was found for interventions conducted by a multidisciplinary team compared with a physician and nurse approach, or for psychossocial interventions which included patients' caregivers compared with patient-only approaches.
Harvard University1, University of California, San Francisco2, Cleveland Clinic3, Azusa Pacific University4, Vanderbilt University5, University of Minnesota6, University of Alberta7, Case Western Reserve University8, Duke University9, New York University10, Cardiovascular Institute of the South11, Campbell University12, Emory University13, Georgetown University14, University of Virginia15, Ohio State University16, University of Missouri–Kansas City17, University of Wisconsin-Madison18
TL;DR: Although the largest ADHF trial to date (ASCEND-HF, using nesiritide) was neutral, promising results with other investigational agents have been reported and novel compounds, such as relaxin, omecamtiv mecarbil, and ularitide, among others, may become therapeutic options.
TL;DR: Although CPX is an established prognostic assessment in the HF population, the results of the present investigation indicate that it may also have important diagnostic utility for PH.
TL;DR: Men appeared to develop ABS as a consequence of a physical trigger, whereas young women had a higher rate of psychiatric comorbidities and a greater propensity for recurrence.
TL;DR: The 1,000 mL/d fluid restriction led to improved quality of life (QoL) at 60 days after discharge, and future research in a larger more heterogeneous sample is needed.
TL;DR: CTGF may be a key regulator of fibrosis during maladaptive remodeling and progression to HF and may be related to a concomitant reduction in MMP9 mRNA and protein levels following unloading.
TL;DR: The SHOP and PEOPLE studies are the first prospective multicenter studies defining the epidemiology and interethnic differences among patients with HF in the Asia-Oceanic region, and will provide unique insights into the pathophysiology and outcomes for these patients.
TL;DR: Acute MSLV was acutely safe, and a proportion of MSLV vectors resulted in a significant reduction in echocardiographic dyssynchrony compared with conventional CRT.
TL;DR: SCA patients have similar load-dependent but lower load-independent measures of LV systolic function than control subjects, and LV structural and functional abnormalities appear to be age dependent with progressive LV dilation and impairment over time.
TL;DR: With appropriate cardiac intervention, the majority of patients with LVEf decline from cancer therapy can achieve LVEF recovery and complete their cancer therapy.
TL;DR: In patients with ADHF, CysC-based CKD-EPI equations were superior to the MDRD equation for predicting mortality and/or HF hospitalization especially in patients with >60 mL min(-1) 1.73 m(-2), and both CKD/CysC equations improved clinical risk stratification.
TL;DR: Despite comprehensive pharmacotherapy, elevated HVR is prevalent in CHF patients, related to severity of the disease and associated with augmented hemodynamic responses to hypoxia, and may be prone to unfavorable hemodynamic changes.
TL;DR: The nature and magnitude of benefit from MSC after acute MI is strongly influenced by timing of cell delivery, with dose dependence most evident for early intervention, with potential implications for cell therapy after MI in human patients.
TL;DR: ASV improves the prognosis of CHF patients with CKD and SDB, with favorable effects such as the improvement of cardiorenal function and attenuation of inflammation and sympathetic nervous activity.
TL;DR: An overview of sleep-disordered breathing in patients with heart failure is provided and a clinical care pathway is proposed to help clinicians to better recognize and treat SDB in their HF patients.